Taliaz, Dekel http://orcid.org/0000-0002-8886-2136
Spinrad, Amit http://orcid.org/0000-0003-0158-6464
Barzilay, Ran
Barnett-Itzhaki, Zohar http://orcid.org/0000-0001-9891-9397
Averbuch, Dana
Teltsh, Omri http://orcid.org/0000-0003-3422-809X
Schurr, Roy http://orcid.org/0000-0003-2374-0821
Darki-Morag, Sne
Lerer, Bernard http://orcid.org/0000-0002-9914-632X
Funding for this research was provided by:
European Commission (832230, 832230, 832230, 832230, 832230, 832230, 832230, 832230)
Israeli Innovation Authority
Article History
Received: 10 January 2021
Revised: 13 May 2021
Accepted: 16 June 2021
First Online: 8 July 2021
Competing interests
: DT is the founder and CEO of Taliaz and reports stock ownership in Taliaz. RB is on the scientific advisory board of Taliaz and reports stock ownership in Taliaz. RB is employed by the University of Pennsylvania and The Children’s Hospital of Philadelphia, and he contributed to this study in his personal capacity, and this manuscript does not reflect the views of his employer. BL is on the scientific advisory board of Taliaz and has received consulting fees from Taliaz. During the research phase of the study, AS, ZB-I, DA, OT, RS, and SD-M served as data scientists in Taliaz. ZB-I is currently employed by Ruppin Academic Center and the Israeli Ministry of Health, and this manuscript does not reflect the views of his current employers.